Clinical Trials Directory

Trials / Completed

CompletedNCT00780923

Effect of Continuous Positive Airway Pressure Treatment on Inflammation in Patients With Obstructive Sleep Apnea

A Longitudinal Study of Short-Term Effects of CPAP Treatment on Airway and Systemic Inflammation in Patients With Obstructive Sleep Apnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Kyoto University, Graduate School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effects of CPAP treatment on airway and systemic inflammation in obstructive sleep apnea.

Detailed description

Obstructive sleep apnea (OSA) is characterised by repetitive episodes of upper airway obstruction during sleep. Systemic and airway inflammation has been recently shown to be associated with OSA and is hypothesized to contribute to the clinical manifestation and the complications of OSA patients. Continuous positive airway pressure (CPAP) is a first-line treatment for OSA and improves diurnal and nocturnal symptoms. However, the effectiveness of CPAP in reversing airway inflammation is less compelling in comparison to systemic inflammation. This study will assess NO in exhaled breath, inflammatory biomarkers in induced sputum and blood of OSA patients and other clinical measurements before and after 3 months of CPAP treatment.

Conditions

Interventions

TypeNameDescription
DEVICECPAP treatmentmaintains upper airway patency and minimizes the obstructive events

Timeline

Start date
2009-01-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2008-10-28
Last updated
2013-03-27

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00780923. Inclusion in this directory is not an endorsement.